These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. First experiences with HeartMate 3 follow-up and adverse events. Hanke JS; Dogan G; Rojas SV; Zoch A; Feldmann C; Deniz E; Avsar M; Warnecke G; Haverich A; Schmitto JD J Thorac Cardiovasc Surg; 2017 Jul; 154(1):173-178. PubMed ID: 28268010 [TBL] [Abstract][Full Text] [Related]
11. Validation of mitral regurgitation reversibility in patients with HeartMate 3 LVAD implantation. Schreiber C; Dieterlen MT; Garbade J; Borger MA; Sieg F; Spampinato R; Dobrovie M; Meyer AL Artif Organs; 2022 Jan; 46(1):106-116. PubMed ID: 34398476 [TBL] [Abstract][Full Text] [Related]
12. One-year outcomes with the HeartMate 3 left ventricular assist device. Hanke JS; Dogan G; Zoch A; Ricklefs M; Wert L; Feldmann C; Bara C; Shrestha M; Tillmanns J; Kempf T; Bauersachs J; Haverich A; Schmitto JD J Thorac Cardiovasc Surg; 2018 Aug; 156(2):662-669. PubMed ID: 29525258 [TBL] [Abstract][Full Text] [Related]
13. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362 [TBL] [Abstract][Full Text] [Related]
14. An 18-month comparison of clinical outcomes between continuous-flow left ventricular assist devices. Itzhaki Ben Zadok O; Ben-Avraham B; Shaul A; Hammer Y; Rubachevski V; Aravot D; Kornowski R; Ben-Gal T Eur J Cardiothorac Surg; 2019 Dec; 56(6):1054-1061. PubMed ID: 31566245 [TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices. Maltais S; Topilsky Y; Tchantchaleishvili V; McKellar SH; Durham LA; Joyce LD; Daly RC; Park SJ J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1370-6. PubMed ID: 21839483 [TBL] [Abstract][Full Text] [Related]
16. Use of left ventricular assist device (HeartMate II): a Singapore experience. Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937 [TBL] [Abstract][Full Text] [Related]
17. Effect of concomitant mitral valve procedures for severe mitral regurgitation during left ventricular assist device implantation. Kawabori M; Kurihara C; Conyer RT; Critsinelis AC; Sugiura T; Rosengart T; Morgan JA J Artif Organs; 2019 Jun; 22(2):91-97. PubMed ID: 30361785 [TBL] [Abstract][Full Text] [Related]
18. Effect of cardiac arrest with aortic cross-clamping during left ventricular assist device implantation. Kawabori M; Kurihara C; Critsinelis A; Chou BP; Zhang Q; Kaku Y; Civitello AB; Morgan JA Interact Cardiovasc Thorac Surg; 2020 Jan; 30(1):47-53. PubMed ID: 31535130 [TBL] [Abstract][Full Text] [Related]
19. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial. Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857 [TBL] [Abstract][Full Text] [Related]
20. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]